Flagship Pioneering as of Dec. 31, 2018
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 7 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 43.9 | $899M | 59M | 15.29 | |
| Rubius Therapeutics | 30.1 | $616M | 38M | 16.08 | |
| Evelo Biosciences | 11.6 | $237M | 18M | 13.01 | |
| Denali Therapeutics (DNLI) | 9.0 | $184M | 8.9M | 20.66 | |
| Seres Therapeutics (MCRB) | 2.8 | $57M | 13M | 4.52 | |
| Quanterix Ord (QTRX) | 1.8 | $37M | 2.0M | 18.31 | |
| Syros Pharmaceuticals | 0.9 | $18M | 3.2M | 5.57 |
